1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Arribas JR, Girard PM, Landman R, Pich J, Mallolas J, Martínez-Rebollar M, Zamora FX, Estrada V, Crespo M, Podzamczer D, Portilla J, Dronda F, Iribarren JA, Domingo P, Pulido F, Montero M, Knobel H, Cabié A, Weiss L, Gatell JM, OLE/RIS-EST13 Study Group.

    Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial

    LANCET INFECTIOUS DISEASES . 15(7): 785-792. Nº de citas: 121

    [doi:10.1016/S1473-3099(15)00096-1]

  • Aldámiz-Echevarría T, González-García J, Von Wichmann MA, Crespo M, López-Aldeguer J, Quereda C, Téllez MJ, Galindo MJ, Sanz J, Santos I, Guardiola JM, Bellón JM, Montes M, Berenguer J.

    Association of baseline CD4+cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients

    ANNALS OF HEPATOLOGY . 14(4): 464-469. Nº de citas: 1

    [doi:10.1016/S1665-2681(19)31167-6]

  • Perez-Molina JA, Rubio R, Rivero A, Pasquau J, Suárez-Lozano I, Riera M, Estébanez M, Santos J, Sanz-Moreno J, Troya J, Mariño A, Antela A, Navarro J, Esteban H, Moreno S.

    Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

    LANCET INFECTIOUS DISEASES . 15(7): 775-784. Nº de citas: 103

    [doi:10.1016/S1473-3099(15)00097-3]

  • Norman FF, Monge-Maillo B, Perez-Molina JA, de Ory F, Franco L, Sánchez-Seco MP, López-Vélez R.

    Lymphadenopathy in Patients With Chikungunya Virus Infection Imported From Hispaniola: Case Reports

    JOURNAL OF TRAVEL MEDICINE . 22(4): 272-275. Nº de citas: 3

    [doi:10.1111/jtm.12204]

  • Abad-Fernández M, Dronda F, Moreno A, Casado JL, Pérez-Elías MJ, Quereda C, Moreno S, Vallejo A.

    Reduced Cell-Associated HTLV-2 DNA in Antiretroviral Treated HIV-1-HCV-Coinfected Patients Who Either Received Interferon-alpha/Ribavirin-Based Hepatitis C Therapy or Had Spontaneous HCV RNA Clearance

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 69(3): 286-290. Nº de citas: 3

    [doi:10.1097/QAI.0000000000000608]

  • Vázquez-Castellanos JF, Serrano-Villar S, Latorre A, Artacho A, Ferrús ML, Madrid N, Vallejo A, Sainz T, Martínez-Botas J, Ferrando-Martínez S, Vera M, Dronda F, Leal M, Del Romero J, Moreno S, Estrada V, Gosalbes MJ, Moya A.

    Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals

    MUCOSAL IMMUNOLOGY . 8(4): 760-772. Nº de citas: 179

    [doi:10.1038/mi.2014.107]

  • Boggild AK, Esposito DH, Kozarsky PE, Ansdell V, Beeching NJ, Campion D, Castelli F, Caumes E, Chappuis F, Cramer JP, Gkrania-Klotsas E, Grobusch MP, Hagmann SH, Hynes NA, Lim PL, López-Vélez R, Malvy DJ, Mendelson M, Parola P, Sotir MJ, Wu HM, Hamer DH, GeoSentinel Surveillance Network.

    Differential Diagnosis of Illness in Travelers Arriving From Sierra Leone, Liberia, or Guinea: A Cross-sectional Study From the GeoSentinel Surveillance Network

    ANNALS OF INTERNAL MEDICINE . 162(11): 757-764. Nº de citas: 31

    [doi:10.7326/M15-0074]

  • Brunetta J, Moreno Guillén S, Antinori A, Yeni P, Wade B, Johnson M, Shalit P, Ebrahimi R, Johnson B, Walker I, De-Oertel S.

    Patient-Reported Outcomes After a Switch to a Single-Tablet Regimen of Rilpivirine, Emtricitabine, and Tenofovir DF in HIV-1-Positive, Virologically Suppressed Individuals: Additional Findings From a Randomized, Open-Label, 48-Week Trial.

    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH . 8(3): 257-267. Nº de citas: 13

    [doi:10.1007/s40271-015-0123-2]

  • Torre-Cisneros J, San-Juan R, Rosso-Fernández CM, Silva JT, Muñoz-Sanz A, Muñoz P, Miguez E, Martín-Dávila P, López-Ruz MA, Vidal E, Cordero E, Montejo M, Blanes M, Fariñas MC, Herrero JI, Rodrigo J, Aguado JM.

    Tuberculosis Prophylaxis With Levofloxacin in Liver Transplant Patients Is Associated With a High Incidence of Tenosynovitis: Safety Analysis of a Multicenter Randomized Trial

    CLINICAL INFECTIOUS DISEASES . 60(11): 1642-1649. Nº de citas: 36

    [doi:10.1093/cid/civ156]

  • Bañón S, Rosillo M, Gómez A, Pérez-Elias MJ, Moreno S, Casado JL.

    Effect of a monthly dose of calcidiol in improving vitamin D deficiency and secondary hyperparathyroidism in HIV-infected patients

    Endocrine . 49(2): 528-537. Nº de citas: 16

    [doi:10.1007/s12020-014-0489-2]

  • Rodríguez-Baño J, Cisneros JM, Cobos-Trigueros N, Fresco G, Navarro-San Francisco C, Gudiol C, Horcajada JP, López-Cerero L, Martínez JA, Molina J, Montero M, Paño-Pardo JR, Pascual A, Peña C, Pintado V, Retamar P, Tomás M, Borges-Sa M, Garnacho-Montero J, Bou G.

    Executive summary of the diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 33(5): 338-341. Nº de citas: 8

    [doi:10.1016/j.eimc.2014.11.015]

  • Rodríguez-Baño J, Cisneros JM, Cobos-Trigueros N, Fresco G, Navarro-San Francisco C, Gudiol C, Horcajada JP, López-Cerero L, Martínez JA, Molina J, Montero M, Paño-Pardo JR, Pascual A, Peña C, Pintado V, Retamar P, Tomás M, Borges-Sa M, Garnacho-Montero J, Bou G.

    Diagnosis and antimicrobial treatment of invasive infections due to multidrug-resistant Enterobacteriaceae. Guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 33(5): 337-337. Nº de citas: 18

    [doi:10.1016/j.eimc.2014.11.009]

  • Puig-Asensio M, Ruiz-Camps I, Fernández-Ruiz M, Aguado JM, Muñoz P, Valerio M, Delgado-Iribarren A, Merino P, Bereciartua E, Fortún J, Cuenca-Estrella M, Almirante B, CANDIPOP Project, GEIH-GEMICOMED (SEIMC), and REIPI.

    Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain.

    CLINICAL MICROBIOLOGY AND INFECTION . 21(5): .

    [doi:10.1016/j.cmi.2014.12.027]

  • Monge-Maillo B, López-Vélez R.

    Miltefosine for Visceral and Cutaneous Leishmaniasis: Drug Characteristics and Evidence-Based Treatment Recommendations

    CLINICAL INFECTIOUS DISEASES . 60(9): 1398-1404. Nº de citas: 46

    [doi:10.1093/cid/civ004]

  • Sánchez-Montalvá A, Martínez-Pérez Á, Pérez-Molina JA, González-López JJ, Lopez-Vélez R, Salvador F, Sánchez I, Planes AM, Molina I.

    Clinical and Microbiological Profile of a Retrospective Cohort of Enteric Fever in 2 Spanish Tertiary Hospitals

    Medicine . 94(21): . Nº de citas: 2

    [doi:10.1097/MD.0000000000000791]

  • Serrano-Villar S, Sobrino-Vegas P, Monge S, Dronda F, Hernando A, Montero M, Viciana P, Clotet B, Pineda JA, Del Amo J, Moreno S.

    Decreasing prevalence of HCV coinfection in all risk groups for HIV infection between 2004 and 2011 in Spain

    JOURNAL OF VIRAL HEPATITIS . 22(5): 496-503. Nº de citas: 13

    [doi:10.1111/jvh.12353]

  • Bruyand M, Ryom L, Shepherd L, Fatkenheuer G, Grulich A, Reiss P, de Wit S, D Arminio Monforte A, Furrer H, Pradier C, Lundgren J, Sabin C, D:A:D study group.

    Cancer Risk and Use of Protease Inhibitor or Nonnucleoside Reverse Transcriptase Inhibitor-Based Combination Antiretroviral Therapy: The D:A:D Study

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 68(5): 568-577. Nº de citas: 29

    [doi:10.1097/QAI.0000000000000523]

  • HIV-CAUSAL Collaboration, Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JA, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA.

    Boosted Lopinavir- Versus Boosted Atazanavir-Containing Regimens and Immunologic, Virologic, and Clinical Outcomes: A Prospective Study of HIV-Infected Individuals in High-Income Countries

    CLINICAL INFECTIOUS DISEASES . 60(8): 1262-1268. Nº de citas: 4

    [doi:10.1093/cid/ciu1167]